NL-OMON21444尚未招募不适用
Angiotensin II receptor blockers in patients with systemic right ventricles.
Academic Medical CentreMeibergdreef 91105 AZ AmsterdamThe Netherlands0 个研究点目标入组 128 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 128
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •All adult patients with a systemic right ventricle due to a congenitally or surgically corrected transposition of the great arteries.
排除标准
- •1. Incapable of giving informed consent;
- •2. Hypersensitivity to valsartan or any of its help substances;
- •3. Known bilateral renal artery stenosis;
- •4. Current symptomatic hypotension;
- •5. Myocardial infarction, stroke or open-heart surgery in the previous four weeks;
- •6. Previous heart transplant, or expected heart transplant within the next six months;
- •7. Plasma creatinine level > 250 µmol/L;
- •8. Plasma potassium level > 5,5 mmol/L;
- •9. Pregnant or nursing women (a pregnancy test is offered to every female patient within the fertile age);
- •10. Desire to have children within the study period;
- •11. Current treatment of hypertension with Angiotensin II receptor blockers or ACE inhibitors.
研究者
相似试验
撤回
3 期
Angiotensin II receptor blockers in patients with systemic right ventricles.Transposition of the great arteriescongenitally corrected transposition of the great arteries10010394NL-OMON30035Academisch Medisch Centrum128
进行中(未招募)
1 期
Angiotensin II receptor blockers in patients with systemic right ventricle.Systemic right ventricle due to total transposition of the great arteries or congenitally corrected transposition of the great arteriesEUCTR2006-002262-19-NLovartis Pharma B.V.
已完成
不适用
Angiotensin II Receptor Blockers in patients with systemic right ventriclesISRCTN52352170Academic Medical Center (AMC) (The Netherlands)128
已完成
不适用
The effects of angiotensin II receptor blockers (ARBs) on oxidative stress and atherosclerosis in patients with hypertension.Patients with hypertensionJPRN-UMIN000001300Second Department of Internal Medicine, Nagasaki University School of Medicine120
已完成
4 期
Combination Therapy of Angiotensin II Receptor Blocker and Calcium Channel Blocker Exerts Pleiotropic Therapeutic Effects in Addition to Blood Pressure LoweringHypertensionJPRN-UMIN000002531Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine30
